文献速递泌尿生殖与妇科肿瘤放疗

南澳大利亚非转移性前列腺癌根治性放疗模式差异(2005-2015)

Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005-2015.
PubMed 文献 · Radiother Oncol · 2020-01-21

该研究基于南澳大利亚前列腺癌临床结局协作数据库,纳入2005-2015年接受根治性放疗的1874例非转移性前列腺癌男性,分析社会人口学因素与放疗模式(外照射 vs 近距离治疗)及技术的关系。结果显示80%接受外照射、20%接受近距离治疗;高龄和偏远居住与接受外照射的可能性相关,近年诊断与中高危患者接受外照射可能性降低相关,近距离治疗中低剂量率使用随时间下降。

要点

  • 低中危患者中,65-74岁较<65岁更可能接受外照射而非近距离治疗。
  • 区域/偏远居民较低危患者接受外照射的可能性低于城市居民。
  • 中高危患者近年诊断者接受外照射可能性降低,低剂量率近距离治疗使用下降。

核心结论

  • 过去十年非转移性前列腺癌根治性放疗模式发生显著变化,高龄和偏远居住可能阻碍获得特定类型放疗。

研究设计与样本

  • 基于南澳大利亚前列腺癌临床结局协作数据库的回顾性队列研究,纳入2005-2015年接受根治性放疗的非转移性前列腺癌男性1874例,排除辅助、挽救和姑息治疗。

主要发现

  • 1874例中80%接受外照射放疗,20%接受近距离治疗。
  • 低危和中危患者中,65-74岁相比<65岁接受外照射的OR分别为3.08(95%CI 1.82-5.22)和3.48(95%CI 2.28-5.31)。
  • 低危和中危患者中,区域/偏远居民相比城市居民接受外照射的OR分别为0.34(95%CI 0.17-0.67)和0.57(95%CI 0.34-0.94)。
  • 中危和高危患者中,较近年诊断与接受外照射可能性降低相关,OR分别为0.22(95%CI 0.15-0.33)和0.50(95%CI 0.29-0.88)。
  • 接受近距离治疗者中,低危和中危患者低剂量率近距离治疗使用随时间下降,OR分别为0.19(95%CI 0.04-0.89)和0.32(95%CI 0.12-0.84)。

临床怎么用

  • 应关注高龄和偏远地区患者放疗可及性差异,优化服务供给以减少模式差异。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To investigate associations between socio-demographic characteristics and radiotherapy patterns of care in non-metastatic prostate cancer [nmPCa] in South Australia [SA] between 2005-2015 and document practice patterns over time. MATERIALS AND METHODS: Men with nmPCa receiving primary curative radiotherapy were identified from SA Prostate Cancer Clinical Outcomes Collaborative database. Adjuvant, salvage and palliative therapies were excluded. Associations between socio-demographic factors (age, residence, socio-economic status, diagnostic period) and radiotherapy mode (external beam radiotherapy [EBRT] vs. brachytherapy [BT]) and technique (low-dose-rate vs. high-dose-rate brachytherapy) were investigated using multivariable logistic regression with separate models for clinical risk categories. RESULTS: Of the 1874 men who underwent primary RT, 80% received EBRT and 20% BT. For low and intermediate risk disease, likelihood of receiving EBRT was higher among older men (ORlow = 3.08; 95% CI 1.82-5.22 and ORintermediate = 3.48; 2.28-5.31 for 65-74 yrs vs. <65 yrs) and lower among regional/remote compared with metropolitan residents (ORlow = 0.34; 0.17-0.67 and ORintermediate = 0.57; 0.34-0.94). For intermediate and high risk disease, more recent diagnosis was associated with decreased likelihood of EBRT (ORintermediate = 0.22; 95% CI 0.15-0.33 and ORhigh = 0.50; 0.29-0.88, respectively). Among men receiving BT, low-dose-rate BT use decreased over time for low (OR = 0.19; 0.04-0.89) and intermediate risk disease (OR = 0.32; 0.12-0.84). Dose escalation and intensity modulation for EBRT increased after 2010. CONCLUSION: Over the last decade substantial changes in RT for nmPCa were observed. Older age and more remote residence may be barriers to accessing specific types of RT. Further research to understand how these factors affect access is warranted to improve service provision.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Morias S, Buckley E, Beckmann K, et al. Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005-2015. Radiother Oncol. 2020. PMID: 31978853. doi:10.1016/j.radonc.2019.12.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。